HIV Clinical Trials in San Francisco, California

33 recruitingSan Francisco, California

Showing 120 of 33 trials

Recruiting

The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

HIV
University of California, San Francisco50 enrolled1 locationNCT01202305
Recruiting

The Use of Leukapheresis to Support HIV Pathogenesis Studies

HIV
University of California, San Francisco100 enrolled1 locationNCT01161199
Recruiting
Phase 2

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled7 locationsNCT06665646
Recruiting
Phase 3

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting

Collection of Blood for Multiple Collaborative Studies

HIV
University of California, San Francisco2,000 enrolled1 locationNCT01336855
Recruiting
Phase 1Phase 2

CAR-T Cells for HIV Infection

HIV Infections
Steven Deeks18 enrolled2 locationsNCT04648046
Recruiting
Phase 2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

HIV InfectionAnal Squamous Cell CarcinomaStage II Rectal Cancer AJCC v8+7 more
National Cancer Institute (NCI)40 enrolled14 locationsNCT04929028
Recruiting
Not Applicable

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

Behavioral InterventionViral Suppression of HIV InfectionART Adherence
University of California, San Francisco270 enrolled1 locationNCT07125235
Recruiting
Phase 2

Improving Physical Ability and Cellular Senescence Elimination in HIV

FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Not Applicable

Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation

HIV
University of California, San Francisco400 enrolled5 locationsNCT05887557
Recruiting
Not Applicable

Wellness, Intervention Strategies and HIV Care

HIVSubstance Use Disorder (SUD)
University of California, San Francisco50 enrolled2 locationsNCT07069374
Recruiting
Phase 2

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

HIV
National Institute of Allergy and Infectious Diseases (NIAID)42 enrolled6 locationsNCT06796686
Recruiting

Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

HIV InfectionsHPV-Related MalignancyHPV Infection
University of California, San Francisco135 enrolled1 locationNCT07087145
Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Anal CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+9 more
AIDS Malignancy Consortium200 enrolled8 locationsNCT05663502
Recruiting
Not Applicable

Text Education About Cardiovascular Health and HIV (TEACH-HIV)

Cardiovascular DiseasesAtherosclerosisHIV+1 more
University of California, San Francisco260 enrolled2 locationsNCT05642858
Recruiting

People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

HIV InfectionsOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
University of California, San Francisco144 enrolled1 locationNCT06055868
Recruiting
Early Phase 1

Pharmacokinetics Distribution of Raltegravir by PET/MR

HIV-1-infection
University of California, San Francisco10 enrolled1 locationNCT03174977
Recruiting
Phase 4

PrEP Intervention for People Who Inject Substances and Use Methamphetamine

HIV Infections
San Francisco Department of Public Health140 enrolled1 locationNCT04523519